Christophe Galtier confirms Messi's departure from PSG
The coach of the Paris Saint-Germain (PSG), Christopher Galtierconfirmed this Thursday in a press conference that Saturday will be the last game of the Argentine striker Lionel Messi in it Princes Parkwhich means that next season he will not wear the club's shirt.
Prior to the day against the clermontGaltier confirmed the departure of the Argentine star from the Parisian club.
I have had the privilege of directing the best player in the history of football. It is a great privilege. Tomorrow is his last game at the Parque de los PrĂncipes and I hope he will be well received.
The coach stressed that Messi was an "important" player this year for PSGafter a first season in which the Argentine striker had to adapt because it was the first time he had left Barcelona.
About him he highlighted that he was "always available" and always "present" in training and that although there were criticshe finds them âcompletely unjustifiedâ.
It has been a great privilege to not only train him but accompany him throughout the season.
In his last game in Paris, Messi will face Clermont in the last day of a League in which Paris has already declared itself winner last week.
messi came in August 2021 to PSG with a contract of two seasons plus a third in option.
Behind the Qatar World CupIt seemed that the player and the club would activate that extra year, but in recent weeks the positions have drifted apart.
The 35-year-old footballer, seven times Ballon d'Or and world champion with Argentina in 2022will lower various offers, a pharaonic one from Saudi Arabiathe largest contract in football history.
But there are other options, such as returning to the Barcelona or sign for him Miami Inter.
(With information from EFE)
Author Profile
- Allow me to introduce myself. I am Nathan Rivera, a dedicated journalist who has had the privilege of writing for the online newspaper Today90. My journey in the world of journalism has been a testament to the power of dedication, integrity, and passion.
My story began with a relentless thirst for knowledge and an innate curiosity about the events shaping our world. I graduated with honors in Investigative Journalism from a renowned university, laying the foundation for what would become a fulfilling career in the field.
What sets me apart is my unwavering commitment to uncovering the truth. I refuse to settle for superficial answers or preconceived narratives. Instead, I constantly challenge the status quo, delving deep into complex issues to reveal the reality beneath the surface. My dedication to investigative journalism has uncovered numerous scandals and shed light on issues others might prefer to ignore.
I am also a staunch advocate for press freedom. I have tirelessly fought to protect the rights of journalists and have faced significant challenges in my quest to inform the public truthfully and without constraints. My courage in defending these principles serves as an example to all who believe in the power of journalism to change the world.
Throughout my career, I have been honored with numerous awards and recognitions for my outstanding work in journalism. My investigations have changed policies, exposed corruption, and given a voice to those who had none. My commitment to truth and justice makes me a beacon of hope in a world where misinformation often prevails.
At Today90, I continue to be a driving force behind journalistic excellence. My tireless dedication to fair and accurate reporting is an invaluable asset to the editorial team. My biography is a living testament to the importance of journalism in our society and a reminder that a dedicated journalist can make a difference in the world.
Latest entries
Celebrities27/09/2023Jana Kramer Shares Bonding Moment Between Her Fiancé and Ex-Husband
Celebrities27/09/2023Regina BlandĂłn reacts to resemblance to Pee Wee
North America27/09/2023Which state would be most affected by the government shutdown?
Latin America27/09/2023PRD and PAN warn about cuts in the 2024 Budget project for the health sector; shortage of cancer drugs continues